{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:30:15Z","timestamp":1789979415438,"version":"4.0.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.2515\/therapie\/2012017","type":"journal-article","created":{"date-parts":[[2012,8,8]],"date-time":"2012-08-08T13:39:00Z","timestamp":1344433140000},"page":"231-236","source":"Crossref","is-referenced-by-count":8,"title":["Peut-on am\u00e9liorer la notification des effets ind\u00e9sirables dans les \u00e9tablissements hospitaliers ? Bilan de 5 ans d\u2019activit\u00e9 du r\u00e9seau PharmacoMIP"],"prefix":"10.1016","volume":"67","author":[{"given":"Julien","family":"Jacquot","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mireille","family":"Gony","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Baudrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Chastel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Louis","family":"Montastruc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haleh","family":"Bagheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.2515\/therapie\/2012017_bb0760","first-page":"416","article-title":"Organisation et resultants de la pharmacovigilance en France","volume":"42","author":"B\u00e9gaud","year":"1994","journal-title":"Rev Epidemiol Sant\u00e9 Publique"},{"key":"10.2515\/therapie\/2012017_bb0765","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1001\/jama.287.17.2215","article-title":"Timing of new black box warnings and withdrawals for prescription medications","volume":"17","author":"Lasser","year":"2002","journal-title":"JAMA"},{"key":"10.2515\/therapie\/2012017_bb0770","unstructured":"Bensadon AC, Marie E, Morelle A. Rapport sur la pharmacovigilance et gouvernance de la cha\u00eene du m\u00e9dicament, http:\/\/www.igas.gouv.fr\/IMG\/pdf\/RM2011-103P_pharmacovigilance-2.pdf."},{"key":"10.2515\/therapie\/2012017_bb0775","unstructured":"D\u00e9cret n\u00b0 95\u2013278 du 13 mars 1995 relatif \u00e0 la pharmacovigilance et modifiant le code de la sant\u00e9 publique. Journal Officiel du 14 mars 1995, pp 3935\u20138, http:\/\/www.legifrance.gouv.fr."},{"key":"10.2515\/therapie\/2012017_bb0780","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/00002018-200629050-00003","article-title":"Under-reporting of adverse drug reactions: a systematic review","volume":"5","author":"Hazell","year":"2006","journal-title":"Drug Safe"},{"key":"10.2515\/therapie\/2012017_bb0785","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1046\/j.1365-2125.1999.00060.x","article-title":"Attitudinal survey of voluntary reporting of adverse drug reactions","volume":"48","author":"Eland","year":"1999","journal-title":"Br J Clin Pharmacol"},{"key":"10.2515\/therapie\/2012017_bb0790","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1365-2125.1991.tb05512.x","article-title":"Geographical differences in adverse drug reactions reporting rates in the Northern Region","volume":"31","author":"Bateman","year":"1991","journal-title":"Br J Clin Pharmacol"},{"key":"10.2515\/therapie\/2012017_bb0795","series-title":"\u00c9valuation du r\u00e9seau de pharmacovigilance de Midi-Pyr\u00e9n\u00e9es","author":"Oscar","year":"2003"},{"key":"10.2515\/therapie\/2012017_bb0800","first-page":"455","article-title":"Adverse drug effect notifications by nurses and comparison with cases reported by physicians","volume":"5","author":"Sacilotto","year":"1995","journal-title":"Therapie"},{"key":"10.2515\/therapie\/2012017_bb0805","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2165\/11319170-000000000-00000","article-title":"Improving adverse drug reactions reporting in hospitals. Results of the French pharmacovigilance in Midi-Pyr\u00e9n\u00e9es Region (PharmacoMIP) network 2-year pilot study","volume":"5","author":"Gony","year":"2010","journal-title":"Drug Saf"},{"key":"10.2515\/therapie\/2012017_bb0810","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1365-2125.2008.03119.x","article-title":"Reversible posterior leukoencephalopathy syndrome associated with bevacizumab\/doxorubicin regimen","volume":"65","author":"B\u00fcrki","year":"2008","journal-title":"Br J Clin Pharmacol"},{"key":"10.2515\/therapie\/2012017_bb0815","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2165\/00002018-200932010-00007","article-title":"An intervention to improve spontaneous adverse drug reaction reporting by hospital physicians","volume":"1","author":"Pedros","year":"2009","journal-title":"Drug Saf"},{"key":"10.2515\/therapie\/2012017_bb0820","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1136\/bmj.300.6716.22","article-title":"Stimulating reporting of adverse drug reaction by using a fee","volume":"300","author":"Feely","year":"1990","journal-title":"BMJ"},{"key":"10.2515\/therapie\/2012017_bb0825","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s00228-005-0072-0","article-title":"A small economic inducement to stimulate increased reporting of adverse drug reactions: a way of dealing with an old problem?","volume":"62","author":"B\u00e4ckstrom","year":"2006","journal-title":"Eur J Clin Pharmacol"},{"key":"10.2515\/therapie\/2012017_bb0830","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s00228-007-0274-8","article-title":"Adverse drug reaction reporting by nurses in Sweden","volume":"63","author":"B\u00e4ckstr\u00f6m","year":"2007","journal-title":"Eur J Clin Pharmacol"},{"key":"10.2515\/therapie\/2012017_bb0835","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1046\/j.1365-2125.2003.01903.x","article-title":"The involvement of nurses in reporting suspected adverse drug reactions: experience with the meningococcal vaccination scheme","volume":"56","author":"Ranganathan","year":"2003","journal-title":"Br J Clin Pharmacol"},{"issue":"9366","key":"10.2515\/therapie\/2012017_bb0840","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/S0140-6736(03)13043-7","article-title":"Reporting of adverse drug reactions by nurses","volume":"361","author":"Morrison-Griffiths","year":"2003","journal-title":"Lancet"},{"key":"10.2515\/therapie\/2012017_bb0845","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1365-2125.1993.tb04183.x","article-title":"Bridging the gap between clinical pharmacology and rational drug prescribing","volume":"35","author":"Ramsay","year":"1993","journal-title":"Br J Clin Pharmacol"}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716308332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716308332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T11:37:54Z","timestamp":1554291474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595716308332"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0040595716308332"],"URL":"https:\/\/doi.org\/10.2515\/therapie\/2012017","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}